Unique ID issued by UMIN | UMIN000056968 |
---|---|
Receipt number | R000065059 |
Scientific Title | A Prospective Observational Study on the Establishment of a Novel Method for Assessing Steatotic Liver Disease Using Magnetic Resonance Imaging (MRI) |
Date of disclosure of the study information | 2025/02/07 |
Last modified on | 2025/02/07 13:48:18 |
A Prospective Observational Study on the Establishment of a Novel Method for Assessing Steatotic Liver Disease Using Magnetic Resonance Imaging (MRI)
A Prospective Observational Study on the Establishment of a Novel Method for Assessing Steatotic Liver Disease Using Magnetic Resonance Imaging (MRI)
A Prospective Observational Study on the Establishment of a Novel Method for Assessing Steatotic Liver Disease Using Magnetic Resonance Imaging (MRI)
A Prospective Observational Study on the Establishment of a Novel Method for Assessing Steatotic Liver Disease Using Magnetic Resonance Imaging (MRI)
Japan |
Steatotic Liver Disease
Medicine in general | Hepato-biliary-pancreatic medicine | Endocrinology and Metabolism |
Radiology |
Others
NO
To establish a method for accurately quantifying the total hepatic fat content using MR images of steatotic liver disease with volume rendering software.
Bio-equivalence
Exploratory
Others
Not applicable
The correlation between whole-liver MRI proton density fat fraction (PDFF) values and PDFF values based on region of interest (ROI) set for each liver segment.
Observational
18 | years-old | <= |
Not applicable |
Male and Female
Individuals who have been identified with steatotic liver or liver dysfunction through blood tests or imaging studies in general medical examinations or health check-ups within one year prior to study enrollment.
1. Individuals with a history or treatment history of liver diseases other than steatotic liver.
2. Individuals with an average daily pure ethanol intake of 30 g or more for men and 20 g or more for women.
3. Individuals who cannot undergo MRI due to the presence of metal implants in the body, claustrophobia, or other reasons.
4. Individuals who are unable to hold their breath for approximately 15 seconds.
5. Individuals with dementia or psychiatric disorders which make it difficult to understand the study.
6. Individuals deemed unsuitable by the principal investigator or the attending physician for other reasons.
12
1st name | Takaaki |
Middle name | |
Last name | Matsuda |
University of Tsukuba Hospital
Department of Endocrinology and Metabolism
305-8576
2-1-1 Amakubo, Tsukuba
029-853-3053
matsuda.takaaki.dd@ms.hosp.tsukuba.ac.jp
1st name | Takaaki |
Middle name | |
Last name | Matsuda |
University of Tsukuba Hospital
Department of Endocrinology and Metabolism
305-8576
2-1-1 Amakubo, Tsukuba, Ibaraki
0298533053
matsuda.takaaki.dd@ms.hosp.tsukuba.ac.jp
University of Tsukuba Hospital
University of Tsukuba Hospital
Other
Clinical research ethics committee of the University of Tsukuba Hospital
2-1-1 Amakubo, Tsukuba, Ibaraki
029-853-3914
matsuda.takaaki.dd@ms.hosp.tsukuba.ac.jp
NO
2025 | Year | 02 | Month | 07 | Day |
Unpublished
Preinitiation
2025 | Year | 01 | Month | 13 | Day |
2025 | Year | 01 | Month | 23 | Day |
2025 | Year | 02 | Month | 07 | Day |
2025 | Year | 06 | Month | 30 | Day |
Prospective study evaluating the total hepatic fat content using MR images of steatotic liver with volume rendering software.
2025 | Year | 02 | Month | 07 | Day |
2025 | Year | 02 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065059